Anti-GP IIb/IIIa chimeric monoclonal antibody F(ab')2 (Shanghai Yalian Antibody)

抗人血小板膜糖蛋白IIb/IIIa嵌合单抗F（ab’）2（上海亚联抗体）

Report date: 2022/07/15 15:58:58

Base Information

Drug NameAnti-GP IIb/IIIa chimeric monoclonal antibody F(ab')2 (Shanghai Yalian Antibody)
Drug Alias Name抗人血小板膜糖蛋白IIb/IIIa嵌合单抗F(ab’)2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragment
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Yalian Antibody Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Yalian Antibody Medicine Co Ltd
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A